No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
MBRX Moleculin Biotech
- 1.6700
- -0.1400-7.73%
Close Dec 20 16:00 ET
- 1.6700
- 0.00000.00%
Post 20:01 ET
5.33MMarket Cap-0.14P/E (TTM)
1.8900High1.6700Low59.29KVolume1.8000Open1.8100Pre Close104.00KTurnover2.13%Turnover RatioLossP/E (Static)3.19MShares15.750052wk High0.71P/B4.66MFloat Cap1.670052wk Low--Dividend TTM2.79MShs Float731.7000Historical High--Div YieldTTM12.16%Amplitude1.6700Historical Low1.7540Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Moleculin Biotech Releases Corporate Presentation Update
Moleculin Biotech Offering Stock Together With Series C and Series D Warrants
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
What's Going On With Moleculin Biotech Shares Wednesday?
Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia
Moleculin Announces Online Publication Of Preclinical Data Demonstrating Significant Activity Of Annamycin In Venetoclax Resistant AML Model
Heat List
US
Overall
Symbol
Price
% Chg
No Data